about
Liver transplantation for viral hepatitis in 2015Nutrition and metabolism in hepatocellular carcinomaSmad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseasesTh1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinomaInvolvement of inflammation and its related microRNAs in hepatocellular carcinomaFrom hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanismsMolecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPKInflammation- and stress-related signaling pathways in hepatocarcinogenesisMaraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse modelCirrhosis is present in most patients with hepatitis B and hepatocellular carcinomaInvolvement of DNA damage response pathways in hepatocellular carcinoma.Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4Pathways of distinction analysis: a new technique for multi-SNP analysis of GWAS data.Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma.Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatmentHepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinomaDiagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma.Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients.Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.The association between preoperative serum C-reactive protein and hepatocellular carcinoma recurrence in patients with chronic hepatitis B virus (HBV) infection--a retrospective study.Effects of statins on the risk of hepatocellular carcinomaMolecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.Immunotherapy for hepatocellular carcinoma: From basic research to clinical use.A lymphotoxin-driven pathway to hepatocellular carcinoma.Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analoguesHepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinomaChronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections.Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceHapMap-based study of CIP2A gene polymorphisms and HCC susceptibility.SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy.TNF-α -863 polymorphisms and the risk of hepatocellular carcinoma.ChARM: Discovery of combinatorial chromatin modification patterns in hepatitis B virus X-transformed mouse liver cancer using association rule miningOnco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma.The role of AEG-1 in the development of liver cancer.Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.
P2860
Q26773224-4C301C2E-4721-481D-9202-1CABDE6A448AQ26862862-726594DE-9AE5-4A86-B101-8FF98D3DA8C1Q26863522-19F63ED4-FD5E-4819-832F-81082C7FD336Q26863635-11E49679-854A-4F21-BCDE-2E9EDCB2CF28Q28079138-F0263895-0E88-4298-A80E-AC843A668307Q28383729-313764FC-6F07-473A-88D1-5C534DB0C29AQ28384866-721719EE-43B8-4B85-86DA-DD65C4982C14Q28387669-EE197F6D-57D6-4142-942F-2B5104DF769EQ28484915-D5F6DC1E-8A6E-4263-8AF9-DE46E4621633Q33391833-915621DF-34E7-4A6F-9714-7A79B89F68F8Q33616812-AE7ECD10-AF7E-4A81-9408-85FC231D6FE8Q33640766-2382AD2A-ED0D-4662-B186-8E3FAB25F0E7Q33939800-85A194B8-D137-40F9-BE09-6391F8D2A59AQ34187221-A79235EF-D272-4AA2-AA01-FC14CBC61FF7Q34200816-A5F51B3C-11FC-47A3-A8BB-4FE1E0F33123Q34347862-73368B7F-6C39-472E-99E4-0FBA3C752E78Q34359262-EA262E48-77C8-496B-894A-745CA2A93849Q34461237-FAC6DD59-09F5-4135-8247-30EFC7957063Q34511085-F6019D9B-200B-4C5F-AE28-FF4D13112753Q34548411-8F15CAA6-BD99-4B0E-A563-FD33F123AE03Q34708248-DD25B258-8A60-47A1-A539-463B310DC0B6Q34934974-6F7D3E54-F08A-4298-96E6-5D47CB15E3BDQ34989402-108F3AE4-1368-43B5-AA81-5F033DFACB49Q34997752-6DB11FBC-39C6-45F0-9003-06F6F9ED00A0Q35048768-5DA2BC92-7748-472C-946E-4DD902F81D98Q35107341-19D15CB9-49B9-4CC6-94B2-2A5C57630347Q35567765-765B7C0A-81CF-4C1E-A7F5-D25D57B04003Q35575883-64FDF842-AE46-423F-BD6F-BEC56A8400D0Q35668724-DA62B354-6630-41B2-8432-B72FB3906BF9Q35889547-637B1258-356A-4916-ABFE-7E79AB8BD578Q36055039-9B648E07-C2D4-4649-A670-FF275A4B0B20Q36067334-00255104-0B4B-4742-867D-BCA5F66C2643Q36110377-16069C05-528A-467D-9E73-951FDFE45585Q36195422-2899CEF1-75CB-4ADE-9A37-B2694BFAAB14Q36224804-B25EABAF-6C36-4815-96FA-24F4B3BC49A5Q36255027-FC65D5BE-F0DA-4634-B7E9-83FD5831048EQ36347633-70E68EB1-7833-46E7-B235-655813A9354AQ36476816-907F02F8-EC02-4ACB-860B-85EAFF533D16Q36603556-B119806C-E7C6-417F-9576-A39F55AF08E5Q36625697-B904F92E-6076-4BDE-8501-7CB1BDC9863A
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The role of cytokines in hepatocellular carcinoma.
@ast
The role of cytokines in hepatocellular carcinoma.
@en
type
label
The role of cytokines in hepatocellular carcinoma.
@ast
The role of cytokines in hepatocellular carcinoma.
@en
prefLabel
The role of cytokines in hepatocellular carcinoma.
@ast
The role of cytokines in hepatocellular carcinoma.
@en
P356
P1476
The role of cytokines in hepatocellular carcinoma.
@en
P2093
Anuradha Budhu
Xin Wei Wang
P304
P356
10.1189/JLB.0506297
P577
2006-08-31T00:00:00Z